Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children, a Randomized Clinical Trial

NCT05240456 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT05240456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05240456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children, a Randomized Clinical Trial
Lead sponsor
Mansoura University
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 28, 2022
Completion date
December 31, 2022
Enrollment
70 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, voiding disorders